» start page / index

 » ECP 2007

 » Cytology 2008

 » IAP seminars

 » University of Helsinki
    weekly seminars

 » Tampere University
    Hospital seminars

 » various seminars

 » search

21st European Congress of Pathology
Istanbul, Turkey, September 08-13, 2007
http://www.ecp2007istanbul.org/
Slide Seminar 11, September 12th
Diagnostic Challenges in Nephropathology
Chairperson: D. Ferluga

 

 

 Return to seminar page

 
Slide 9  
Case 9
Presented by: Heinz Regele

Clinical History
Patient H.H., male, 64 years old at time of biopsy Native kidney disease: unknown, no Bx available 1st dialysis 1986 1st renal Tx in 1988 Tx failure in 1995 (chronic rejection and membranous glomerulonephritis) Dialysis from 1995-1999 07/99: 2nd renal Tx, 95% PRA (panel reactive antibodies). Desensitisation treatment consisting of pre- and post-Tx immunoadsorption and additional induction therapy with ALG was started according to a local protocol. The patient suffered from delayed graft function but could be discharged from the hospital at 3 weeks post Tx with SCr of 1,2mg%
12/2001: Tx-Bx (SCr 2,2mg%): Banff borderline lesion. 2003: increasing proteinuria, an allograft biopsy did not contain diagnostically adequate tissue.
02/2004: Tx-Bx performed during surgical intervention required for perirenal hematoma causing hydronephrosis and oliguria (patient is on oral anticoagulation (Cumarin) for atrial fibrillations)
Other clinical data at time of Bx: SCr 4,9mg% Proteinuria 7g/24h Hepatitis C with high virus load
03/2004: Patient returns to dialysis
  
  Membranous GN of the allograft (most likely recurrent). Cholesterol embolism. No convincing evidence for currently active rejection (g2, i1, t0, ah0, cg0, ci2, ct2, mm2)  
  Please post comments!
 
 
Comments on this case:

Post a new comment on this case

 
Subject Posted Author Replies
28.12.2007
   


All material on this website is protected by copyright. By accessing or downloading contents
from this website, you expressly agree and consent to our terms and conditions.